Colonic Neoplasms Clinical Trial
— CASSANDRA IOfficial title:
Computer Assisted Selection of Serrated Adenomas and Neoplastic Polyps - a New Clinical Draft
Verified date | May 2018 |
Source | Technische Universität München |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The aim of the study is to develop a computer program which is able to classify different
entities of colorectal polyps on the basis of optical polyp features. In the end, the
computer program shall differentiate between (i) hypeplastic polyps, (ii) adenomas and (iii)
serrated adenomas .
In the first phase of the study a computer program will be established which aims to
distinguish between the above mentions entities on the basis of optical features derived from
still images. A machine learning apporach will be used for creating the program. Afterwards,
in a second phase of the study, still images of 100 polyps (not used in the first phase) will
be presented to the computer program. Quality of the computer program will be tested by
calculating the accuracy for differentiating the three different polyp types. The gold
standard for true polyp diagnoses will be based on histopathological diagnoses of the polyps.
The same pictures of 100 polyps will also be presented to human experts. Experts will also
predict histopathological diagnoses on the basis of optical polyps featurs. Accuracy of
computer-decisions and human expert predictions will be compared. The establishment of a
well- functioning computer program is the primary aim of the study.
Status | Not yet recruiting |
Enrollment | 300 |
Est. completion date | May 15, 2019 |
Est. primary completion date | December 15, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 99 Years |
Eligibility |
Inclusion Criteria: - indication for colonoscopy - patients >= 18 years Exclusion Criteria: - pregnant women - indication for colonoscopy: inflammatory bowel disease - indication for colonoscopy: polyposis syndrome - indication for colonoscopy: emergency colonoscopy e.g. acute bleeding - contraindication for polyp resection e.g. patients on warfarin |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Technische Universität München |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Assessment of the computer- made optical diagnosis of each colorectal polyp | The predicted polyp histology (made optically by the computer program) will be assessed; the predicted diagnosis will be compared with the histopathological diagnosis (gold standard) after resection of the polyp; | participants data will be followed for the duration of creating the computer program (an expected average of 2 month) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03746353 -
Early Closure Versus Conventional Closure in Postoperative Patients With Low Anteriresection for Rectal Cancer
|
N/A | |
Recruiting |
NCT05809999 -
IBD Neoplasia Surveillance RCT
|
N/A | |
Recruiting |
NCT06041945 -
Artificial Intelligence to Implement Cost-saving Strategies for Colonoscopy Screening Based on in Vivo Prediction of Polyp Histology
|
N/A | |
Not yet recruiting |
NCT02688699 -
Additive Hemostatic Efficacy of EndoClot After EMR or ESD in the Gastrointestinal Tract
|
Phase 4 | |
Not yet recruiting |
NCT03175146 -
A Study to See Whether Stereotactic Body RadioTherapy (SBRT) Can Shrink Tumours Within the Liver Safely
|
N/A | |
Completed |
NCT02529007 -
Endo-cuff Assisted Vs. Standard Colonoscopy for Polyp Detection in Bowel Cancer Screening
|
N/A | |
Not yet recruiting |
NCT01929499 -
Efficacy of Adjuvant Cytokine-induced Killer Cells in Colon Cancer
|
Phase 2 | |
Completed |
NCT01681472 -
PK/PD Investigation of Modufolin (Arfolitixorin) in Plasma, Tumor and Adjacent Mucosa Adjacent Mucosa in Patients With Colon Cancer
|
Phase 1/Phase 2 | |
Completed |
NCT01438645 -
ScopeGuide-assisted Colonoscopy Versus Conventional Colonoscopy
|
N/A | |
Completed |
NCT00535652 -
Concentration of Ertapenem in Colorectal Tissue
|
Phase 4 | |
Terminated |
NCT00267787 -
Molecular Genetic and Pathological Studies of Anal Tumors
|
||
Completed |
NCT05498051 -
Fluorescent Sentinel Lymph Node Identification in Colon Carcinoma Using Submucosal Bevacizumab-800CW.
|
N/A | |
Recruiting |
NCT05068180 -
Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients
|
Phase 4 | |
Recruiting |
NCT03314896 -
Laparoscopic Surgery for T4 Tumor of the Colon Cancer (LST4C Trial)
|
N/A | |
Not yet recruiting |
NCT02852915 -
Laparoscopic Surgery for T4 Tumor of the Colon Cancer
|
Phase 3 | |
Not yet recruiting |
NCT02777437 -
Laparoscopic Surgery VS Laparoscopic Surgery + Neoadjuvant Chemotherapy for T4 Tumor of the Colon Cancer
|
Phase 2/Phase 3 | |
Completed |
NCT00997802 -
Japanese National Computed Tomographic (CT) Colonography Trial
|
N/A | |
Completed |
NCT01056913 -
NITI CAR27 (ColonRing) Compression Anastomosis in Colorectal Surgery
|
Phase 4 | |
Completed |
NCT00470782 -
Aerobic Capacity and Body Composition in Colon Cancer Patients
|
N/A | |
Completed |
NCT00537901 -
First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study
|
N/A |